Get the latest Science News and Discoveries
Repurposed drug may help stabilize vision in rare disease - EurekAlert
Ophthalmologist Rajendra S. Apte, MD, PhD, (right), of Washington University School of Medicine in St. Louis, examines patient Patricia Collins (left) while medical student Wilson Wang observes. Collins is a participant in a clinical trial that tests the safety and efficacy of an FDA-approved drug in stabilizing vision in patients with RVCL-S, a rare genetic disease that affects tiny blood vessels in the body.
None
Or read this on Eureka Alert